PHARMARON (03759.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec22

Kangbok Chemical's Shareholders Reduce Holdings by 18.4819 million Shares

00:52

Dec18

Kanglong Chem Beijing Co., Ltd. Holds Extraordinary General Meeting and Approves Multiple Resolutions

12:43

Dec12

Kangbok Chemical Shareholders Reduce Holdings by 1%

00:50

Nov17

Kanglong Chemical Beijing Co., Ltd Acquires Biortus to Enhance Its CRO Market Position

09:41

Kanglong Huacheng Acquires Bayoreader for 1346 Million Yuan

09:15

Cinda International Securities Upgrades Kanglong Chemical's Rating and Target Price

08:35

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 3.984 B, Net Income 480.46 M, EPS 0.272

Aug21

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 3.658 B, Net Income 433.23 M, EPS 0.2457

Aug6

Distribution Plan(CST)

Cash dividend 0.2187 HKD

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change